Sapiens_Val

Clinical Trial for Evaluating New Diabetes Medication

Recruiting
18 years - 100 years
Male
Fase 3
55 participants needed
1 Location

Brief description of study

Val_ainfo.io (formal)

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Asthma, Acne
  • Age: 18 years - 100 years
  • Gender: Male



Updated on 19 Feb 2024. Study ID: TX13191

This clinical trial aims to evaluate the effectiveness and safety of a new medication for managing diabetes. Participants will be monitored over a period of 12 months to assess the medication's impact on blood sugar levels and overall health.

  • Who Can Participate: Adults aged 18-65 with a diagnosis of type 2 diabetes who are not currently on insulin therapy
  • Study Details: The study involves taking the medication daily and attending monthly check-ups to monitor health and progress
  • Study Timelines and Visits: The study will run for a total of 12 months.Participants are required to attend 12 monthly visits during the study period

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language